本试剂盒应用双抗体夹心酶标免疫分析法测定标本中MIP-1β水平。用纯化的抗体包被微孔板,制成固相抗体,往包被单抗的微孔中依次加入MIP-1β抗原、生物素化的抗大鼠MIP-1β抗体、HRP标记的亲和素,经过彻底洗涤后用底物TMB显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的MIP-1β呈正相关。用酶标仪在450nm波长下测定吸光度(OD值),计算样品浓度。 
 
Intended use
This immunoassay kit allows for the specific measurement of rat MIP-1β concentrations in cell culture supernates, serum, and plasma.
 
Introduction
The two variants of the Macrophage Inflammatory Protein 1, designated MIP-1α and MIP-1β, belong to the β or CC chemokine subfamily. The two chemokines were originally purified from lipopolysaccharidetreated murine monocytic cell lines, hence their designation as "Macrophage Inflammatory Protein". MIP-1α and MIP-1β are produced by stimulated leukocytes as well as other tissue cells and tumor cells. At least seven variants of rat MIP-1β, corresponding to the products of independantly cloned cDNA, including Act-2, G-26, HC-21, HIMAP, H400, pAT 744 and MAD-5, have been described. At the protein levels, mature rat MIP-1β has a length of 69 amino acids and shows a homology of 70% with MIP-1α. MIP-1β is a natural ligand for the chemokine receptors CCR3, CCR5 and CCR8. The effect of MIP-1α and MIP-1β on monocytes and T cells include chemotaxis, a rise in intracellular [Ca2+], expression of integrins and increased adhesion to endothelial cells. The two chemokines provide an important signal for T cell activation resulting in enhanced proliferation, IL-2 secretion and cell surface IL-2 receptor expression. MIP-1α and MIP-1β chemoattract and degranulate NK cells and enhance NK cells as well as CTL mediated cytolysis. Both chemokines induce chemotaxis and [Ca2+] increase in dendritic cells.
 
Test principle
This assay employs the quantitative sandwich enzyme immunoassay technique. A monoclonal
antibody specific for MIP-1β has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and any MIP-1β present is bound by the immobilized antibody. An enzyme-linked monoclonal antibody specific for MIP-1β is added to the wells. Following a wash to remove any unbound antibody-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of MIP-1β bound in the initial step. The color development is stopped and the intensity of the color is measured.